ADPT — Adaptive Biotechnologies Share News
0.000.00%
Last trade - 00:00- $4.70bn
- $4.75bn
- $276.98m
Adaptive Biotechnologies Corporation reports results for the quarter ended September 30 - Earnings Summary
Adaptive Biotechnologies Q3 revenue falls 11% but beats estimates
Brief: Adaptive Biotechnologies Q3 EPS USD 0.02
Advisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates
Brief: Adaptive Biotechnologies Q2 EPS USD -0.25
Brief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile
Adaptive Biotechnologies up after boosted $300 mln convertible bond sale
Brief: Adaptive Biotechnologies Announces Proposed Convertible Senior Notes Offering
Adaptive Biotechnologies plans separation of immune medicine platform
Adaptive Biotechnologies falls after announcing convertible, separation of businesses
Brief: Adaptive Biotechnologies announces plan to separate its MRD and Immune Medicine Businesses